Renovion Competitors and Similar CompaniesClear all
Renovion's competitors and similar companies include JCR Pharmaceuticals, Travere Therapeutics, GBT (Global Blood Therapeutics) and Heron Therapeutics.
 Renovion Renovion (formerly known as The Repairion Group) is a company that develops therapies for chronic inflammatory airway diseases. |  JCR Pharmaceuticals JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products. |  Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. |  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. |  Heron Therapeutics Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development. | |
Founding Date | Founding Date 2013 | Founding Date 1975 | Founding Date 2011 | Founding Date 2012 | Founding Date 1983 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Chapel Hill, US HQ | Locations Ashiya, JP HQ Kobe, JP Kobe, JP Kobe, JP Kobe, JP | Locations San Diego, US HQ Dublin, IE | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations San Diego, US HQ |
Employees | Employees 5 | Employees 934 | Employees 46293% increase | Employees 352106% increase | Employees 20333% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 533.9 m | Valuation ($) 1.4 b | Valuation ($) 4.4 b | Valuation ($) 268.5 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥33.1b (FY, 2025) | Revenue (est.) $490.7m (FY, 2025) | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) $154.9m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥8b (FY, 2025) | Cost of goods $10.3m (FY, 2025) | Cost of goods $3.3m (FY, 2021) | Cost of goods $41.3m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥25.1b (FY, 2025) | Gross profit $480.4m (FY, 2025) | Gross profit N/A | Gross profit $113.6m (FY, 2025) |
Net income | Net income N/A | Net income (¥4.7b) (FY, 2025) | Net income ($25.5m) (FY, 2025) | Net income ($303.1m) (FY, 2021) | Net income ($20.2m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 14.4m | Total funding raised N/A | Total funding raised $ 25m | Total funding raised $ 88.7m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
JCR Pharmaceuticals
HQ
Ashiya, JP
Employees
934
JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products.
View companyTravere Therapeutics
HQ
San Diego, US
Employees
462
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
View companyGBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View companyHeron Therapeutics
HQ
San Diego, US
Employees
203↓ 33% decrease
Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development.
View company